Skip to main content
Premium Trial:

Request an Annual Quote

Caliper Posts Q3 Revenue Rise

SAN DIEGO, Oct. 25 – Caliper Technologies on Thursday posted third-quarter revenues of $6.6 million compared to $5.5 million for the same quarter a year ago, the company announced.

Caliper, based in Mountain View, Calif., recorded a net loss of $8.4 million, or 35 cents per diluted share, for the third quarter of 2001 compared to a net gain of $6.1 million, or 25 cents per diluted share, for the year-ago quarter. Operating expenses increased to $17.2 million for the third quarter of this year from $13.3 million in the same period in 2000.

“Our financial performance for the third quarter 2001 reflects several strategic initiatives we undertook to expand and strengthen our high throughput screening business as well as continuing strength in sales of the Agilent 2100 Bioanalyzer,” Jim Knighton, CFO of Caliper, said in a statement. “These strategies have had the positive effect of continuing the trend toward increasing our revenue as well as positively impacting the percentage of our revenues deriving from product sales, as contrasted with licensing fees and R&D contract services.”

Knighton cited increases in cost of goods sold associated with increased product sales and an increase in marketing and sales investment as impacting the bottom line.

During the third quarter, Caliper spun out an independently funded and managed chemical genomics database company named Amphora Discovery, of which Caliper owns 28 percent. 

“Amphora is, and will be, a significant customer for Caliper's new HTS systems,” Dan Kisner, CEO of Caliper, said in a statement. “When fully operational, Amphora has the potential to become the world's largest and most productive high throughput screening center.”

As of September 30, 2001, Caliper had $170.4 million in cash and investments.

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.